COMPLETED

Scotoma Perimetry Oculomotor Training

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed research is relevant to public health because a greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function and preservation of sight. Declines in vision are particularly common in older adults and thus increasing our understanding of how to cre- ate effective means of improving vision is also highly relevant to the mission of the NIA to support research on aging and the health and well-being of older people.

Official Title

New Methods to Quantify and Train Eye Movement Strategies in Macular Degeneration

Quick Facts

Study Start:2022-11-01
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05456581

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Severely impaired vision in both eyes (20/100 or worse)
  2. * Diagnosis of Macular Degeneration
  3. * Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (SLO, MAIA)
  4. * Medical record review indicates this disease severity level has been present for at least 2 years.
  1. * Inability to sit still in eye tracker for extended periods
  2. * Inability to visualize iris on video eye tracker
  3. * Bilateral retinal scotomas larger than 20° diameter

Contacts and Locations

Study Locations (Sites)

UAB
Birmingham, Alabama, 35294
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-01
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2022-11-01
Study Completion Date2025-06-30

Terms related to this study

Keywords Provided by Researchers

  • plasticity
  • central vision loss

Additional Relevant MeSH Terms

  • Macular Degeneration
  • Central Visual Impairment